AAAAAA
Results:
1-12
|
Results: 12
Authors:
Perno, CF
Cozzi-Lepri, A
Balotta, C
Forbici, F
Violin, M
Bertoli, A
Facchi, G
Pezzotti, P
Cadeo, G
Tositti, G
Pasquinucci, S
Pauluzzi, S
Scalzini, A
Salassa, B
Vincenti, A
Phillips, AN
Dianzani, F
Appice, A
Angarano, G
Monno, L
Ippolito, G
Moroni, M
Monforte, AD
Citation: Cf. Perno et al., Secondary mutations in the protease region of human immunodeficiency virusand virologic failure in drug-naive patients treated with protease inhibitor-based therapy, J INFEC DIS, 184(8), 2001, pp. 983-991
Authors:
Fabris, P
Tositti, G
Manfrin, V
Giordani, MT
Vaglia, A
Cattelan, AM
Carlotto, A
Citation: P. Fabris et al., Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients?, J ACQ IMM D, 25(1), 2000, pp. 92-93
Authors:
Infantolino, C
Fabris, P
Infantolino, D
Biasin, MR
Venza, E
Tositti, G
Minucci, D
Citation: C. Infantolino et al., Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: a retrospective study in 314 cases, EUR J OB GY, 93(1), 2000, pp. 71-75
Authors:
Fabris, P
Biasin, MR
Infantolino, D
Tositti, G
Venza, E
Floreani, A
Zanetti, A
de Lalla, F
Citation: P. Fabris et al., TTV infection in patients with acute hepatitis of defined aetiology and inacute non-A-E hepatitis, J HEPATOL, 32(4), 2000, pp. 661-665
Authors:
Betterle, C
Fabris, P
Zanchetta, R
Pedini, B
Tositti, G
Bosi, E
de Lalla, F
Citation: C. Betterle et al., Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection, DIABET CARE, 23(8), 2000, pp. 1177-1181
Authors:
Romano, L
Fabris, P
Tanzi, E
Tositti, G
Mazzotta, F
Zanetti, AR
Citation: L. Romano et al., GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in Italy, J MED VIROL, 61(1), 2000, pp. 59-64
Authors:
Fabris, P
Marranconi, F
Bozzola, L
Biasin, MR
De Lazzari, F
Plebani, M
Benedetti, P
Tositti, G
Pellizzer, G
Stecca, C
de Lalla, F
Citation: P. Fabris et al., Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN, J GASTRO, 34(3), 1999, pp. 345-350
Authors:
Fabris, P
Infantolino, D
Biasin, MR
Marchelle, G
Venza, E
Marin, VTW
Benedetti, P
Tositti, G
Manfrin, V
de Lalla, F
Citation: P. Fabris et al., High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners, INFECTION, 27(2), 1999, pp. 86-91
Authors:
Fabris, P
Tositti, G
Mazzella, G
Zanetti, AR
Nicolin, R
Pellizzer, G
Benedetti, P
de Lalla, F
Citation: P. Fabris et al., Effect of ursodeoxycholic acid administration in patients with acute viralhepatitis: a pilot study, ALIM PHARM, 13(9), 1999, pp. 1187-1193
Authors:
Fabris, P
Tositti, G
Negro, F
Marranconi, F
Infantolino, D
Rassu, M
De Lalla, F
Citation: P. Fabris et al., Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients, ALIM PHARM, 13(10), 1999, pp. 1329-1334
Authors:
Fabris, P
Manfrin, V
Rassu, M
Tositti, G
de Lalla, F
Zanetti, A
Citation: P. Fabris et al., Triple therapy prevents HIV but not HCV transmission after needlestick injury, AM J GASTRO, 94(7), 1999, pp. 1990-1991
Authors:
Tositti, G
Fabris, P
de Lalla, F
Citation: G. Tositti et al., Incidence, risk factors, and clinical significance of neurological symptoms in adult patients with acute gastroenteritis, AM J GASTRO, 94(10), 1999, pp. 3078-3079
Risultati:
1-12
|